Minireviews
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 101162
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.101162
Table 1 Summary of clinical outcomes and safety in studies comparing microwave ablation with other ablation techniques for colorectal liver metastases
Ref.
Modality
Follow-up (months)
Complication rate (%)
Local recurrence rate (%)
Overall survival (months)
Disease-free survival (months)
Di Martino et al[18], 2020MWA vs RFA3678 (MWA); 12 (RFA)44.538.5
Gavriilidis et al[19], 2021MWA vs RFA vs HR3612532.124.5
Mimmo et al[2], 2022MWA6010634.322
Tinguely et al[4], 2023MWA vs HR601575828
Ammori et al[15], 2013HAI chemotherapy6016184725
Izzo et al[8], 2019RFA vs MWA6610.57.95022
Lucchina et al[14], 2016MWA121063218
Meloni et al[16], 2017MWA36155.22424
Vogl et al[17], 2017MWA3655.23224
Carrafiello et al[29], 2008MWA12563612
Cornelis et al[36], 2017MWA60563218
Facciorusso et al[32], 2020MWA vs RFA3974.3 (MWA); 7.5 (RFA)3922
Moussa et al[40], 2019MWA24852424
Spiliotis et al[41], 2021MWA vs RFA241262424
Tan et al[38], 2019MWA vs RFA24612 (MWA); 15 (RFA)2424
Vietti Violi et al[39], 2018MWA vs RFA241212 (MWA); 14 (RFA)2424
Zheng et al[42], 2018TACE vs TACE + MWA4517617.16.7
Table 2 Advantages and disadvantages of microwave ablation compared with other ablation techniques
Ref.
Modality
Advantages
Disadvantages
Carrafiello et al[29], 2008MWA vs other ablation techniquesHigher intratumoral temperatures, larger ablation zones, less heat-sink effectRequires further studies to confirm long-term effectiveness
Cornelis et al[36], 2017MWA vs RFALess dependent on electrical conductivities, higher temperatures, less desiccationInsufficient long-term data on oncologic effectiveness
Facciorusso et al[32], 2020MWA vs RFABroader zone of active heating, higher temperatures, shorter treatment times, no heat-sink effectBroader and less predictable necrosis areas, uncertain if larger ablation zone translates to survival gain
Moussa et al[40], 2019MWA vs RFAOvercomes limitations of RFA in lung cancer treatment, higher temperatures, larger ablation zonesPotential complications, need for optimal patient selection
Spiliotis et al[41], 2021MWA vs RFABetter oncological outcomes in terms of local tumor progression for HCCRequires high-quality evidence to confirm superiority
Tan et al[38], 2019MWA vs RFALower local recurrence rates in laparoscopic ablationHigher major complication rate in laparoscopic MWA
Vietti Violi et al[39], 2018MWA vs RFALow local tumor progression rates, fewer complicationsNo significant difference in complications between MWA and RFA
Zheng et al[42], 2018MWA vs TACEImproved overall survival, longer time to progressionHigher recurrence rates, potential complications
Ammori et al[15], 2013HAI chemotherapy vs R/AIncreased conversion to resection/ablation, improved long-term survivalOnly 25% of patients respond sufficiently for conversion
Gavriilidis et al[19], 2021MWA vs HR vs RFALess local recurrence, better 3-year and 5-year survivalSignificantly younger patients, lower preoperative CEA
Lucchina et al[14], 2016MWA vs RFAHigher thermal efficiency, no heat-sink effect, suitable for tumors near vesselsRequires further validation for widespread use
Meloni et al[16], 2017MWA vs other ablation techniquesHigh efficacy, fast procedure, good local controlRequires advanced imaging and close follow-up
Mimmo et al[2], 2022MWAHigh local control rates, long-term disease controlRequires optimal patient selection and proper procedural techniques
Tinguely et al[4], 2023MWA vs HRNon-inferior overall survival compared to resection, lower complicationsHigher retreatment rates compared to resection
Vogl et al[17], 2017MWAShorter ablation time, less pain, less heat sink effectNeeds scientific proof of advantages
Wagstaff et al[46], 2014MWA vs RFASimilar oncologic outcomes, better functional and perioperative outcomesLow risk of residual disease, candidates must be properly informed